Dec 1, 2023 04:05PM
Nov 22, 2023 08:30AM
Nov 7, 2023 04:00PM
Nov 7, 2023 04:00PM
Oct 27, 2023 08:30AM
Oct 12, 2023 09:00AM
Oct 4, 2023 04:05PM Veracyte (VCYT) Reports New Data from Phase 3 Trial Further Validating Prognostic Value of Decipher Prostate Genomic Classifier
Oct 4, 2023 04:05PM
Sep 28, 2023 04:05PM
Sep 28, 2023 08:15AM
Sep 27, 2023 09:00AM
Sep 27, 2023 09:00AM
Sep 21, 2023 04:05PM
Aug 22, 2023 08:15AM Veracyte Announces that Findings Published in JCO Precision Oncology Suggest Potential of Decipher GRID-Derived Gene Signatures to Predict Treatment Response in Recurrent Prostate Cancer
Aug 1, 2023 08:15AM
Aug 1, 2023 08:15AM
Jun 20, 2023 08:31AM
Jun 12, 2023 08:31AM
May 25, 2023 05:13PM
May 24, 2023 09:00AM
May 4, 2023 09:45AM New Data Being Presented at AACE 2023 Help Elucidate Cancer Risk of TERT Promoter Gene Mutations in Patients with Indeterminate Thyroid Nodules
May 3, 2023 05:44PM
May 2, 2023 04:06PM
May 2, 2023 04:05PM
May 1, 2023 05:35PM
Apr 29, 2023 04:31PM
Apr 17, 2023 08:30AM
Apr 12, 2023 08:30AM Veracyte Announces Seven Abstracts for Its Decipher Urologic Cancer Tests To Be Presented at 2023 AUA Annual Meeting
Feb 15, 2023 08:38AM
Feb 15, 2023 08:36AM
Feb 13, 2023 05:23PM
Feb 1, 2023 04:05PM
Feb 1, 2023 08:33AM
Feb 1, 2023 08:32AM
Dec 15, 2022 04:05PM Data Published in JCEM Demonstrate Strong Real-World Performance of Veracyte’s Afirma GSC in Thyroid Cancer Diagnosis
Oct 25, 2022 08:30AM
Oct 24, 2022 08:30AM
Oct 18, 2022 04:05PM
Sep 22, 2022 08:56AM
Sep 22, 2022 08:55AM
Sep 13, 2022 08:30AM
Sep 12, 2022 05:43AM Veracyte (VCYT) Reports Strong Phase 3 Data of Decipher Prostate Genomic Classifier
Sep 11, 2022 02:30AM
Sep 7, 2022 04:55PM
Sep 7, 2022 04:54PM
Aug 31, 2022 07:00AM
Jul 20, 2022 04:16PM
Jul 20, 2022 04:15PM
Jul 13, 2022 04:16PM Veracyte (VCYT) Announces Publication of Data Validating Clinical Performance of Veracyte’s Percepta Genomic Sequencing Classifier in Lung Cancer Diagnosis
Jul 13, 2022 04:15PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All